Alimera Sciences, Inc. to Present at the Summer Solstice – Best Ideas from the Buy Side Conference on June 2, 2021
Alimera Sciences, a pharmaceutical company focused on ophthalmic pharmaceuticals, announced its participation in the Summer Solstice - Best Ideas from the Buy Side Conference from June 1-4, 2021. President and CEO Rick Eiswirth will present on June 2 at 10:30 am ET. The presentation will be available via live webcast.
This virtual conference showcases 35 top ideas from qualified institutional investors, focusing on companies with potential for alpha.
- None.
- None.
ATLANTA, May 27, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that management has been invited to present at the Summer Solstice - Best Ideas from the Buy Side Conference, which is being held virtually on June 1 – June 4, 2021.
Rick Eiswirth, President and Chief Executive Officer will deliver his corporate presentation on June 2, 2021 at 10:30am ET.
The presentation will be webcast live and available for replay at https://www.webcaster4.com/Webcast/Page/2134/41505
To receive additional information, request an invitation, please email angie.goertz@issuerdirect.com.
Investors can register here.
About the MicroCap Rodeo Summer Solstice Best Ideas Conference
The MicroCap Rodeo is back with its third "Best Ideas Bowl." This conference is a virtual conference that brings you the top 35 best ideas from the buy side. Qualified institutional investors recommended each of the 35 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're focused on alpha.
About Alimera Sciences, Inc.
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
What is the date of Alimera Sciences' presentation at the Summer Solstice Conference?
Who is presenting for Alimera Sciences at the conference?
What is the focus of the Summer Solstice Conference?
How can I watch Alimera Sciences' presentation?
What is the main focus of Alimera Sciences as a company?
